HER-2/neu Assessment in Breast Cancer by Immunohistochemistry and Fluorescence In Situ Hybridization: Comparison of Results and Correlation With Survival

被引：0
作者：
Sanjay Kakar
Nick Puangsuvan
Jane M. Stevens
Romualda Serenas
George Mangan
Shalini Sahai
Michael L. Mihalov
机构：
[1] University of Illinois at Chicago,Department of Pathology
来源：
Molecular Diagnosis | 2000年 / 5卷 / 3期
关键词：
prognosis; Herceptin;
D O I：
10.1007/BF03262077
中图分类号：
学科分类号：
摘要：
Background: HER-2/neu immunohistochemistry (IHC) and fluorescence insitu hybridization (FISH) results guide breast cancer therapy; however, few studies compared the results and no published studies have correlated them with patient outcome.
引用
收藏
页码：199 / 207
页数：8
相关论文
共 99 条
  • [1] Wisecarver JL(1999)Her-2/neu testing comes of age Am J Clin Pathol 111 299-301
  • [2] Ross JS(1999) gene and protein in breast cancer Am J Clin Pathol 112 S53-S67
  • [3] Fletcher JA(1989)Studies of Science 244 707-712
  • [4] Slamon DJ(1993) proto-oncogene in human breast and ovarian cancer Cancer Res 53 4960-4970
  • [5] Godolphin W(1999)Her-2/neu expression in node negative breast cancer: Direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease Am J Clin Pathol 112 459-469
  • [6] Jones LA(1997)Prognostic significance of p34cdc2 cyclin-dependent kinase and MIB1 overexpression, and J Clin Oncol 15 2894-2904
  • [7] Press MF(1992) gene amplification detected by fluorescence Cancer 69 2953-2960
  • [8] Pike MC(1994) hybridization in breast cancer Cancer 74 2956-2963
  • [9] Chazin VR(1996) gene amplification characterized by fluorescence Oncogene 13 63-72
  • [10] Depowski PL(1989) hybridization: Poor prognosis in node-negative breast carcinomas N Engl J Med 320 525-527
12345678910